Arkolith/Insider Trading/NAVB/Form 4

Scott John K Jr.

Director, 10% OwnerNAVIDEA BIOPHARMACEUTICALS, INC. (NAVB) · full profile →Form 4 · filed Sep 1, 2022
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
1 non-derivative · 3 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Aug 31, 2022Grant(A)3K—$08.1M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Aug 30, 2022Sell(S)2K$1379.31$2.4M0
Aug 30, 2022Buy(P)2K——2K
Aug 30, 2022Buy(P)2K——2K

Transaction Codes

A
Grant / award
S
Open-market sale
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001437749-22-021740) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML